Acrivon Therapeutics, Inc. · NASDAQ:ACRV
Gamelin Erick sold 416 Acrivon Therapeutics, Inc. shares (Form 4)
Traded Nov 17, 2026 · Filed Nov 19, 2026
On Nov 17, 2026, Gamelin Erick (Chief Development Officer) sold 416 Acrivon Therapeutics, Inc. shares at US$1.45 for US$603, leaving 52,176 shares. Filed Nov 19, 2026 (Form 4).
- Sold
- 416 shares
- Price
- US$1.45
- Value
- US$603
- Holding after
- 52,176 shares
- Trading plan
- No
- Role
- Chief Development Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Common Stock | Sale | 416 | US$1.45 | 52,176 | Direct |
Source
Download original · View original at SEC
Related
- Acrivon Therapeutics, Inc.
- Gamelin Erick
- Acrivon Therapeutics, Inc. shareholders
- Form 4 · Gamelin Erick · Aug 20, 2026
- Form 4 · Gamelin Erick · May 20, 2026
- Form 4 · Gamelin Erick · May 18, 2026
- Form 4 · Devroe Eric · Nov 19, 2026
- Form 4 · Blume-Jensen Peter · Nov 19, 2026
- Form 4 · Peterson Katharine · Nov 19, 2026
- Form 4 · Miller Mary · Nov 19, 2026
- Form 4 · Miller Mary · Oct 26, 2026